Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 7
1989 5
1990 3
1991 11
1992 6
1993 5
1994 2
1995 7
1996 9
1997 7
1998 12
1999 13
2000 17
2001 14
2002 13
2003 11
2004 9
2005 13
2006 17
2007 17
2008 22
2009 13
2010 17
2011 27
2012 21
2013 32
2014 25
2015 23
2016 31
2017 41
2018 34
2019 20
2020 32
2021 26
2022 33
2023 24
2024 32
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

594 results

Results by year

Filters applied: . Clear all
Page 1
Primary Sclerosing Cholangitis.
Lazaridis KN, LaRusso NF. Lazaridis KN, et al. N Engl J Med. 2016 Sep 22;375(12):1161-70. doi: 10.1056/NEJMra1506330. N Engl J Med. 2016. PMID: 27653566 Free PMC article. Review. No abstract available.
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Bowlus CL, et al. Hepatology. 2023 Feb 1;77(2):659-702. doi: 10.1002/hep.32771. Epub 2022 Oct 20. Hepatology. 2023. PMID: 36083140 No abstract available.
Pembrolizumab-Induced Sclerosing Cholangitis.
Tahboub Amawi AD, Tremaine WJ, Venkatesh SK. Tahboub Amawi AD, et al. Clin Gastroenterol Hepatol. 2022 Feb;20(2):e18. doi: 10.1016/j.cgh.2020.11.048. Epub 2020 Dec 3. Clin Gastroenterol Hepatol. 2022. PMID: 33279784 No abstract available.
Cholestatic liver disease.
Gossard AA, Talwalkar JA. Gossard AA, et al. Med Clin North Am. 2014 Jan;98(1):73-85. doi: 10.1016/j.mcna.2013.09.002. Epub 2013 Oct 20. Med Clin North Am. 2014. PMID: 24266915 Review.
MicroRNAs in Cholangiopathies.
O'Hara SP, Gradilone SA, Masyuk TV, Tabibian JH, LaRusso NF. O'Hara SP, et al. Curr Pathobiol Rep. 2014 Sep 1;2(3):133-142. doi: 10.1007/s40139-014-0048-9. Curr Pathobiol Rep. 2014. PMID: 25097819 Free PMC article.
Liver Transplant for Cholangiocarcinoma.
Zamora-Valdes D, Heimbach JK. Zamora-Valdes D, et al. Gastroenterol Clin North Am. 2018 Jun;47(2):267-280. doi: 10.1016/j.gtc.2018.01.002. Gastroenterol Clin North Am. 2018. PMID: 29735023 Review.
The 5-year survival rate after LT is 65% to 70%, higher among patients with primary sclerosing cholangitis, who are often diagnosed earlier, and lower among patients with de novo CCA. ...
The 5-year survival rate after LT is 65% to 70%, higher among patients with primary sclerosing cholangitis, who are oft …
Primary sclerosing cholangitis: review for radiologists.
Morgan MA, Khot R, Sundaram KM, Ludwig DR, Nair RT, Mittal PK, Ganeshan DM, Venkatesh SK. Morgan MA, et al. Abdom Radiol (NY). 2023 Jan;48(1):136-150. doi: 10.1007/s00261-022-03655-6. Epub 2022 Sep 5. Abdom Radiol (NY). 2023. PMID: 36063181 Free PMC article. Review.
Primary sclerosing cholangitis is a rare chronic inflammatory disease affecting the bile ducts, which can eventually result in bile duct strictures, cholestasis and cirrhosis. ...
Primary sclerosing cholangitis is a rare chronic inflammatory disease affecting the bile ducts, which can eventually re …
Primary sclerosing cholangitis.
Angulo P, Lindor KD. Angulo P, et al. Hepatology. 1999 Jul;30(1):325-32. doi: 10.1002/hep.510300101. Hepatology. 1999. PMID: 10385674 Review. No abstract available.
594 results